TS

Tarvinder Singh

Director Director DIN 03032744
DIN 03032744 First appointment Dec 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2020
Shareholding value Locked Premium profile

About Tarvinder Singh

Data last updated:

Tarvinder Singh has 5 years in corporate governance. Formerly with 1 company, such as Medient Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03032744
Primary Designation Director
First Appointment 16 Dec 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Additional Director16 Dec 20202015Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medient Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tarvinder Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tarvinder Singh

Tarvinder Singh has 5 years in corporate governance. Formerly with 1 company, such as Medient Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Tarvinder Singh is associated with 0 companies as a director.

Tarvinder Singh has expertise in General Business.

Tarvinder Singh has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available